Trial Profile
Comparison of two basal insulin analogs (insulin lispro protamine suspension and insulin determir) in basal-bolus therapy for patients with type 1 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2022
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin neutral protamine lispro/insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 25 Sep 2008 The actual number of patients enrolled was 388 according to ClinicalTrials.gov record.
- 25 Sep 2008 Status changed from active, no longer recruiting to completed as reported in the ClinicalTrials.gov record.
- 08 May 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.